Science

The 2024 Assisi think tank on breast cancer by Meritxell Arenas et al.

Meritxell Arenas/iispv.cat

Jan 26, 2025, 15:04

The 2024 Assisi think tank on breast cancer by Meritxell Arenas et al.

A recent paper titled “The 2024 Assisi think tank on breast cancer: Focus on the use of a tumour bed boost after breast conserving therapy” was published in The Breast Journal by Meritxell Arenas et al.

Authors: Meritxell Arenas, Yasemin Bölükbaşı, Liesbeth Boersma, Cynthia Aristei, Philip Poortmans et al.

Elisabetta Bonzano, Radiation Oncologist at IRCCS San Matteo Polyclinic Foundation, shared this article on X, commenting:

“The 2024 Assisi think tank on breast cancer: Focus on the use of a tumour bed boost after breast-conserving therapy

The Fifth Assisi Think Tank Meeting on breast cancer discussed tumour bed boost.
Tumour bed boost can reduce local recurrence by up to 50 % but does not impact on overall survival.
If the estimated absolute reduction in local recurrence exceeds 3 % at 10 years, a boost should be suggested.
Balancing tumour bed boost benefits with potential side effects is key to achieving optimal outcomes for patients.
Future research should identify patients who can avoid the boost and refine tumour bed boost volumes for more precise treatments.”

More posts featuring Elisabetta Bonzano.

Assisi Think Tank Boost technique Breast Cancer cancer Cynthia Aristei Dose fractionation Elisabetta Bonzano Liesbeth Boersma local recurrence Meritxell Arenas OncoDaily Oncology Philip Poortmans radiation therapy Target volume definition Tumour bed boost Yasemin Bolukbasi

KIMMTRAK (Tebentafusp) uses in Cancer: Dosages, Indications, Expectations and more

Senator Edward Markey in Response to OncoDaily About Pediatric Cancer Funding

In Memory of Alan Rickman and His Battle with Prostate and Pancreatic Cancer

New Paper Alert: Systemic management of advanced HCC: an increasingly complex game

AC-satoreotide got FDA Orphan Drug Designation status for SCLC and MCC